Market
Elucid raises $55m to advance cardiovascular diagnostic portfolio
Elucid announced a $55 million funding round to accelerate commercial expansion of its cardiovascular diagnostic platform, including its Plaque-IQ diagnostic tool. The proceeds will support scaling of the clinical platform serving cardiologists and related specialists.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network